In summary, TGF-β mediates immune cells–epithelia coupling via the downregulation of T cell glycolysis by competition or ATP synthesis paralysis, thereby decreasing T cell effector function and ultimately promoting cancer progression. This evidence concerns the gene TGFB1 and cancer.